BioNTech to close three German sites. BioNTech stock costs EUR 86.10 in weekend trading
Published on 10/03/2026 at 13:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
On September 28, 2026, BioNTech said it would close German sites that it had failed to sell as it shifts away from pandemic-era manufacturing, according to Reuters. BioNTech stock costs EUR 86.10 in weekend trading at Lang & Schwarz at 12:52 p.m. CEST on October 3, 2026, matching the EUR 86.10 close at Lang & Schwarz on October 2, 2026.
Weekend trading
The EUR 86.10 price was unchanged from the EUR 86.10 close at Lang & Schwarz on October 2, 2026. The quote was recorded at 12:52 p.m. CEST on October 3, 2026. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of BioNTech stock.
Last Xetra trading day
The last Xetra trading day closed at EUR 86.10 at Lang & Schwarz on October 2, 2026. Xetra and the primary exchanges were closed during the weekend trading period.
Gotistobart trial data
In a September 14, 2026 release, BioNTech and OncoC4 reported updated data from stage 1 of the PRESERVE-003 phase 3 trial. Median overall survival was 18.5 months for patients treated with gotistobart versus 10.0 months with docetaxel at the July 17, 2026 data cutoff, according to the BioNTech and OncoC4 release. The trial involved patients with squamous non-small cell lung cancer whose disease had progressed after prior immunotherapy and chemotherapy.
Next Xetra session
The next Xetra session is scheduled for October 5, 2026.
